In conclusion, Our findings suggest that variants of PPARGC1A rs3736265 G>A polymorphism decrease the level of FPG, improving the expectation of study in individual's prevention strategies to T2DM. This evidence concerns the gene PPARGC1A and type 2 diabetes mellitus.